Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LENSAR ( (LNSR) ) has issued an update.
LENSAR, Inc., a medical device company specializing in ophthalmic laser systems for cataract and other eye surgeries, continues to focus on delivering image-guided technologies that support surgeons in achieving greater accuracy and efficiency in the operating room. Its products target the growing market for advanced vision-correction procedures and premium cataract surgery solutions.
On April 10, 2026, LENSAR announced that Chief Financial Officer Thomas R. Staab, II had notified the company of his intention to resign effective May 8, 2026, to pursue other professional opportunities, while remaining principal financial officer through the transition period. The company noted that his departure did not stem from any disagreement over operations, policies, or practices, and has begun a search for a new CFO, signaling an orderly leadership transition in its finance function.
The most recent analyst rating on (LNSR) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on LENSAR stock, see the LNSR Stock Forecast page.
Spark’s Take on LNSR Stock
According to Spark, TipRanks’ AI Analyst, LNSR is a Neutral.
The score is held down primarily by weak financial quality (persistent losses, ongoing cash burn, and negative equity in 2025) and clearly bearish technicals (price well below key moving averages with negative momentum). Offsetting this somewhat, the latest earnings call highlighted improving operational KPIs (recurring revenue and procedure growth) and guidance focused on stabilizing margins and cash flow, but profitability and balance-sheet risk remain key constraints.
To see Spark’s full report on LNSR stock, click here.
More about LENSAR
LENSAR, Inc. operates in the medical device industry, focusing on ophthalmic technologies used in eye surgeries such as cataract procedures. The company develops and markets advanced laser systems designed to assist surgeons in performing precise, image-guided eye operations for improved clinical outcomes and workflow efficiency.
Average Trading Volume: 107,674
Technical Sentiment Signal: Sell
Current Market Cap: $71.61M
See more insights into LNSR stock on TipRanks’ Stock Analysis page.